Ligand profile
F9X
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
F9X- PDB
7bxr- UniProt (similar protein)
Q0K313- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 169.4
- −1 ≤ LogP ≤ 5 0.02
- MW ≤ 500 Da 364.3
- LogP ≤ 5 0.02
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 169.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC[C@H]([C@@H](C(=O)O)NCc1c(cnc(c1O)C)COP(=O)(O)O)OCC[C@H]([C@@H](C(=O)O)NCc1c(cnc(c1O)C)COP(=O)(O)O)O
InChI=1S/C13H21N2O8P/c1-3-10(16)11(13(18)19)15-5-9-8(6-23-24(20,21)22)4-14-7(2)12(9)17/h4,10-11,15-17H,3,5-6H2,1-2H3,(H,18,19)(H2,20,21,22)/t10-,11+/m1/s1InChI=1S/C13H21N2O8P/c1-3-10(16)11(13(18)19)15-5-9-8(6-23-24(20,21)22)4-14-7(2)12(9)17/h4,10-11,15-17H,3,5-6H2,1-2H3,(H,18,19)(H2,20,21,22)/t10-,11+/m1/s1
BXUMTZWSUSTQMU-MNOVXSKESA-NBXUMTZWSUSTQMU-MNOVXSKESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00155
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand F9X →
- PDB RCSB structure 7bxr →
- UniProt UniProt Q0K313 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “F9X”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).